[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.74.94. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Viewpoint
November 19, 2014

Elimination of Lipid Levels From Quality MeasuresImplications and Alternatives

Author Affiliations
  • 1New York City Health and Hospitals Corporation, New York, New York
  • 2Department of Population Health, NYU School of Medicine, New York, New York
JAMA. 2014;312(19):1971-1972. doi:10.1001/jama.2014.15600

On October 31, 2014, the Centers for Medicare & Medicaid Services (CMS) issued an update to the set of quality measures for accountable care organizations under the Medicare Shared Savings Program. The new rule will retire 8 of the 33 measures and add 8 new measures. Notably, the revision will remove all 3 quality measures addressing low-density lipoprotein cholesterol (LDL-C), including (1) percentage of patients aged 18 to 75 years with diabetes and an LDL-C level lower than 100 mg/dL within the past 12 months; (2) percentage of patients 18 years or older with ischemic vascular disease and an LDL-C level lower than 100 mg/dL within the past 12 months; and (3) percentage of patients 18 years or older with a diagnosis of coronary artery disease and an LDL-C level lower than 100 mg/dL within the past 12 months or an LDL-C level of 100 mg/dL or higher and a documented plan of care to achieve a level lower than 100 mg/dL, including at minimum the prescription of a statin.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×